Bell Investment Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48K Sell
21
-20
-49% -$1.08K ﹤0.01% 1439
2026
Q1
$2.14K Sell
41
-9
-18% -$540 ﹤0.01% 1314
2025
Q4
$2.94K Sell
50
-93
-65% -$5.65K ﹤0.01% 1205
2025
Q3
$7.96K Hold
143
﹤0.01% 716
2025
Q2
$7.36K Buy
143
+6
+4% +$301 ﹤0.01% 801
2025
Q1
$8.03K Buy
137
+8
+6% +$542 ﹤0.01% 691
2024
Q4
$9.29K Hold
129
﹤0.01% 630
2024
Q3
$10.3K Hold
129
﹤0.01% 607
2024
Q2
$9.24K Hold
129
﹤0.01% 647
2024
Q1
$9.08K Hold
129
﹤0.01% 633
2023
Q4
$9.95K Sell
129
-25
-16% -$1.65K ﹤0.01% 563
2023
Q3
$10.5K Sell
154
-8
-5% -$632 ﹤0.01% 486
2023
Q2
$13.2K Buy
162
+13
+9% +$1.04K ﹤0.01% 418
2023
Q1
$11.1K Sell
149
-11
-7% -$848 ﹤0.01% 449
2022
Q4
$13.3K Buy
160
+8
+5% +$635 ﹤0.01% 399
2022
Q3
$11K Sell
152
-28
-16% -$2.42K ﹤0.01% 399
2022
Q2
$16K Buy
+180
New +$16.9K ﹤0.01% 316
2021
Q4
$22K Sell
168
-4
-2% -$490 0.01% 296
2021
Q3
$21K Buy
+172
New +$20.9K 0.01% 280

Other funds holding TECH

Bell Investment Advisors's TECH Position: Q2 2026 in Review

Bell Investment Advisors reduced its Bio-Techne (TECH) stake by 49% in Q2 2026, selling an estimated $1.08K and leaving 21 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1439.

Bell Investment Advisors first reported a position in TECH in Q3 2021 and has held it in 19 quarters since. The position peaked at $22K in Q4 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Bell Investment Advisors held 21 shares of Bio-Techne worth $1.48K as of Q2 2026.
  • Bell Investment Advisors sold 20 Bio-Techne shares in Q2 2026, an estimated $1.08K.
  • Bio-Techne made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1439 holding.
  • Bell Investment Advisors first reported a position in Bio-Techne in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Bio-Techne position peaked at $22K in Q4 2021.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.